Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis-based diagnostics unit.

The Swiss pharmaceutical and diagnostics giant said the move will establish the Indianapolis-based Roche Diagnostics, 9115 Hague Road, as a hub for manufacturing of its continuous glucose monitoring system. A continuous glucose monitoring system is a small device worn by the patient with a sensor to monitor glucose levels.

The expansion, which officials said would include a refurbishment of existing facilities and could include future new construction, will create about 650 skilled manufacturing jobs and roughly 1,000 construction jobs. The company currently has 4,815 employees in Indianapolis.

“Indianapolis was a natural choice when we sa

See Full Page